LIVER FAT
Clinical trials for LIVER FAT explained in plain language.
Never miss a new study
Get alerted when new LIVER FAT trials appear
Sign up with your email to follow new studies for LIVER FAT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fatty liver breakthrough? drug that boosts growth hormone shows promise
Disease control CompletedThis study tested a drug called tesamorelin in 51 obese adults with nonalcoholic fatty liver disease (NAFLD). The drug is designed to increase growth hormone levels, which may help reduce liver fat and inflammation. Researchers measured changes in liver fat using special scans an…
Matched conditions: LIVER FAT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Computer nudge boosts liver referrals
Knowledge-focused CompletedThis study tested whether a pop-up alert in the electronic medical record could help doctors remember to refer patients with fatty liver disease (NASH) to a liver specialist. Thirty doctors from internal medicine, family medicine, and endocrinology took part. The goal was to see …
Matched conditions: LIVER FAT
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC